| Journal: | Salud pública de México |
| Database: | PERIÓDICA |
| System number: | 000213481 |
| ISSN: | 0036-3634 |
| Authors: | Lazcano Ponce, Eduardo1 Alonso, Patricia2 Ruiz Moreno, José Antonio3 Hernández Avila, Mauricio |
| Institutions: | 1Instituto Nacional de Salud Pública, Centro de Investigación en Salud Poblacional, Cuernavaca, Morelos. México 2Universidad Nacional Autónoma de México, Facultad de Medicina, México, Distrito Federal. México 3Escuela Militar de Graduados de Sanidad, México, Distrito Federal. México |
| Year: | 2003 |
| Volumen: | 45 |
| Pages: | 449-462 |
| Country: | México |
| Language: | Inglés |
| Document type: | Artículo |
| Approach: | Analítico |
| Spanish abstract | y g) el programa de DOC para garantizar calidad, también deberá satisfacer las expectativas de las usuarias, así como aumentar el conocimiento sobre cáncer cervical. Finalmente, a pesar de que diversos ensayos clínicos de vacunas profilácticas y terapéuticas contra el VPH se desarrollan actualmente a nivel mundial al menos durante un periodo de entre 5 y 10 años las vacunas contra este virus no estarán disponibles comercialmente. Por esta razón, será necesario reforzar las acciones de los programas de DOC. Este artículo también está disponible en: http://www.insp.mx/salud/index.html |
| English abstract | The cervical cancer screening programs (CCSP) have not been very efficient in the developing countries. This explains the need to foster changes on policies, standards, quality control mechanisms, evaluation and integration of new screening alternatives considered as low and high cost, as well as to regulate colposcopy practices and the foundation of HPV laboratories. Cervical cancer (CC) is a disease most frequently found in poverty-stricken communities and reflecting a problem of equity at both levels gender and regional, and this, is not only due to social and economic development inequalities, but to the infrastructure and human resources necessary for primary care. For this reason, the CCSP program must be restructured, a) to primarily address unprivileged rural and urban areas; b) to foster actions aimed at ensuring extensive coverage as well as a similar quality of that coverage in every region; c) to use screening strategies in keeping with the availability of health care services. In countries with a great regional heterogeneity, a variety of screening procedures must be regulated and standardized, including a combination of assisted visual inspection, cervical cytology and HPV detection; d) regional community intervention must be set up to assess the effectiveness of using HPV detection as an strategy in addition to cervical cytology (pap smear); e) the practice of colposcopy must be regulated to prevent the use of it in healthy women at a population level, thus preventing unnecessary diagnosis and treatment which not only are expensive but also causes unnecessary anxiety to women at risk; f) the operation of those clinical laboratories using HPV as a detection strategy must likewise be accredited and regulated and g) the CCSP program for assuring health care quality should meet the expectations of its beneficiaries, and increase the knowledge in cervical cancer related matters |
| Disciplines: | Medicina |
| Keyword: | Diagnóstico, Oncología, Salud pública, Cáncer, Cérvix, Países en desarrollo, Papilomavirus, Citología, Colposcopía, Vacunas, Tamizaje |
| Keyword: | Medicine, Diagnosis, Oncology, Public health, Cancer, Cervix, Developing countries, Papillomavirus, Cytology, Colposcopy, Vaccines, Screening |
| Full text: | Texto completo (Ver PDF) |
